Abstract:Objectives: Most chemotherapy agents cause tumor cell death primarily by the induction of apoptosis. The ability to noninvasively image apoptosis in vivo could dramatically benefit pre-clinical and clinical evaluation of chemotherapeutics targeting the apoptotic pathway. This study aims to visualize the dynamics of apoptotic process with temporal bioluminescence imaging (BLI) using an apoptosis specific bioluminescence reporter gene. Methods: Both UM-SCC-22B human head and neck squamous carcinoma cells and 4T I murine breast cancer cells were genetically modified with a caspase-3 specific cyclic firefly luciferase reporter gene (pcFluc-DEVD). Apoptosis induced by different concentrations of doxorubicin in the transfected cells was evaluated by both annexin V staining and BLI. Longitudinal BLI was performed in xenografted tumor models at different time points after doxorubicin or Doxil treatment, to evaluate apoptosis. After imaging, DNA fragmentation in apoptotic cells was assessed in frozen tumor sections using TUNEL staining. Results: Dose- and time-dependent apoptosis induced by doxorubicin in pcFluc-DEVD transfected UM-SCC-22B and 4T I cells was visualized and quantified by BLI. Caspase-3 activation was confirmed by both caspase activity assay and Glo (TM) luciferase assay. One dose of doxorubicin treatment induced a dramatic increase in BLI intensity as early as 24 h after treatment in 22B-pcFluc-DEVD xenografted tumors. Sustained signal increase was observed for the first 3 days and the fluorescent signal from ex vivo TUNEL staining was consistent with BLI imaging results. Long-term imaging revealed that BLI signal consistently increased and reached a maximum at around day 12 after the treatment with one dose of Doxil. Conclusions: BLI of apoptosis with pcFluc-DEVD as a reporter gene facilitates the determination of kinetics of the apoptotic process in a real-time manner, which provides a unique tool for drug development and therapy response monitoring.

Bioluminescence Imaging of DNA Synthetic Phase of Cell Cycle in Living Animals

Cytokinetic Analysis of Cell Cycle and Sub-Phases in MOLT-4 Cells by Cyclin E + A/DNA Multiparameter Flow Cytometry.

Bioluminescent reporter gene for monitoring DNA (Deoxyribonucleic Acid) synthesis phase and application thereof

The G1 Phase Optical Reporter Serves As a Sensor of CDK4/6 Inhibition in Vivo

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Bioluminescent Imaging of Cdk2 Inhibition in Vivo.

Bioluminescence Imaging of Hollow Fibers in Living Animals: Its Application in Monitoring Molecular Pathways.

S phase reporter gene of cell cycle

Longitudinal Bioluminescence Imaging of the Dynamics of Doxorubicin Induced Apoptosis.

Bioluminescent imaging of ubiquitin ligase activity: measuring Cdk2 activity in vivo through changes in p27 turnover.

Amino‐Acid‐Encoded Supramolecular Nanostructures for Persistent Bioluminescence Imaging of Tumor

Development of luminescent probes for real-time detection of the CDK/PP2A balance during the cell cycle

Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein

Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice

Noninvasive Molecular Imaging Of C-Myc Activation In Living Mice

A Bioluminescent Probe for Imaging Human Cytochrome P450 2J2 Activity in Vitro and in Vivo

Visualization of Mitotic Arrest of Cell Cycle with Bioluminescence Imaging in Living Animals.

Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence

In Vivo Visualization of Fluorescence Reflecting CDK4 Activity in a Breast Cancer Mouse Model

A Bioluminescent Probe for Tumor Hypoxia Detection via CYP450 Reductase in Living Animals.